Rutland Herald

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick ...

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), today announced the U.S. Food and Drug ...

Blockbuster long acting flea and tick treatment for dogs coming after FDA approval

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...
ABC7

FDA approves long-acting flea treatment for dogs, marking veterinary breakthrough

Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. NOTE: This video is from a previous report. The ...
Seeking Alpha

Merck granted FDA approval to expand Bravecto label for tick species in dogs

Merck’s (MRK) animal health unit announced that the U.S. FDA approved a label expansion for its once-yearly parasiticide treatment Bravecto Quantum to treat two additional tick species in dogs.

Best flea and tick treatments for dogs

The best flea and tick treatments for dogs include prescription and OTC medicines that help prevent parasites and serious ...
Morningstar

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick ...

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs ...